APA (7th ed.) Citation

Gómez Almaguer, D., Colunga Pedraza, P. R., Gómez de León, A., Gutiérrez Aguirre, C. H., Cantú Rodríguez, O. G., & Jaime Pérez, J. C. (2019). Eltrombopag, low‐dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.

Chicago Style (17th ed.) Citation

Gómez Almaguer, David, Perla Rocío Colunga Pedraza, Andrés Gómez de León, César Homero Gutiérrez Aguirre, Olga Graciela Cantú Rodríguez, and José Carlos Jaime Pérez. Eltrombopag, Low‐dose Rituximab, and Dexamethasone Combination as Frontline Treatment of Newly Diagnosed Immune Thrombocytopaenia. 2019.

MLA (9th ed.) Citation

Gómez Almaguer, David, et al. Eltrombopag, Low‐dose Rituximab, and Dexamethasone Combination as Frontline Treatment of Newly Diagnosed Immune Thrombocytopaenia. 2019.